Genetic predisposition to blood cell indices in relation to severe COVID‐19

alexandrossfakianakis shared this article with you from Inoreader Genetic predisposition to blood cell indices in relation to severe COVID‐19 via Journal of Medical Virology Abstract Despite of considerable variation in disease manifestations observed among coronavirus disease 2019 (COVID-19) patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the risk factors predicting disease severity remain elusive. Recent studies suggest that peripheral blood cells play a pivotal role in COVID-19 pathogenesis. Here, we applied two-sample Mendelian randomization (MR) analyses to evaluate the potential causal contributions of blood cell indices variation to COVID-19 severity, using single-nucleotide polymorphisms (SNPs) as instrumental variables for seventeen indices from the UK Biobank and INTERVAL genome-wide association studies (N = 173,480). Data on the associations between the SNPs and very severe respiratory confirmed COVID-19 were obtained from the COVID-19 host genetics initiative (N = 8,779/1,001,875). We observed significant negative association between hematocrit (OR = 0.775, 95% CI = 0.635-0.915, P - value = 3.48E-04) or red blood cell count (OR = 0.830, 95% CI = 0.728-0.932, P - value = 2.19E-03) and very severe respiratory confirmed COVID-19, as well as nominal negative association of HGB (OR = 0.808, 95% CI = 0.673-0.943, P = 3.95E-03) with very severe respiratory confirmed COVID-19 (no effect survived multiple correction). In conclusion, the MR study supports a protective effect of high hematocrit and red blood cell count from very severe respiratory confirmed COVID-19, suggesting potential strategies to ameliorate/treat clinical conditions in very severe respiratory confirmed COVID-19. This article is protected by copyright. All rights reserved. View on Web

Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.